Compare TEAM & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEAM | STE |
|---|---|---|
| Founded | 2002 | 1985 |
| Country | Australia | United States |
| Employees | N/A | 3700 |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.5B | 21.6B |
| IPO Year | 2015 | 2018 |
| Metric | TEAM | STE |
|---|---|---|
| Price | $154.21 | $239.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 5 |
| Target Price | $169.18 | ★ $275.20 |
| AVG Volume (30 Days) | ★ 5.0M | 740.3K |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 1.19% |
| EPS Growth | 15.52 | ★ 27.90 |
| EPS | N/A | ★ 7.93 |
| Revenue | $5,215,304,000.00 | ★ $5,935,900,000.00 |
| Revenue This Year | $24.65 | $9.88 |
| Revenue Next Year | $17.67 | $6.32 |
| P/E Ratio | ★ N/A | $30.04 |
| Revenue Growth | ★ 19.66 | 8.73 |
| 52 Week Low | $56.01 | $195.14 |
| 52 Week High | $180.24 | $269.44 |
| Indicator | TEAM | STE |
|---|---|---|
| Relative Strength Index (RSI) | 80.31 | 68.35 |
| Support Level | $139.70 | $229.31 |
| Resistance Level | $166.48 | $267.89 |
| Average True Range (ATR) | 6.83 | 6.31 |
| MACD | 6.30 | 1.34 |
| Stochastic Oscillator | 99.27 | 94.72 |
Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.